Creating vaccines and driving value through partnerships and R&D | Novavax
Novavax is a global biotechnology company with a proven vaccine technology, focused on developing our R&D assets and establishing partnerships to help protect health.
Is the Novavax COVID Vaccine Better Than mRNA Vaccines? What …
Oct 16, 2023 · Novavax’s protein-based vaccine is the latest FDA-authorized COVID booster available this fall. Here’s what you should know
Novavax COVID-19 vaccine - Wikipedia
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, [1] among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for Epidemic Preparedness Innovations.
FDA Authorizes Updated Novavax COVID-19 Vaccine to Better …
FDA authorized for emergency use Novavax COVID-19 Vaccine (2024-2025 Formula) to more closely target currently circulating variants to provide better protection against serious consequences of ...
Novavax Update: Where to Find Our COVID-19 Vaccine
Oct 7, 2024 · Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) is indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older.
Schedule your COVID-19 Vaccine Appointment | Novavax
The Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) has not been approved or licensed by FDA, but has been authorized for emergency use by FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 …
Novavax's COVID-19 Vaccine: Your Questions Answered
Sep 3, 2024 · The new Novavax vaccine targets a SARS-CoV-2 variant called JN.1, which was the dominant strain in May 2024, only to be surpassed by a collection of other Omicron virus strains, including KP.2, for which the mRNA vaccines were updated to protect against.
Novavax 2024-2025 Formula COVID-19 Vaccine Available at …
Aug 30, 2024 · Doses of Novavax's 2024-2025 Formula COVID-19 vaccine now available at thousands of locations nationwide; Novavax's updated vaccine is the only protein-based option available in the U.S. this fall for individuals aged 12 and older
Committed to creating vaccines to help protect health | Novavax
Novavax is a global biotechnology company with a proven vaccine technology. We’re focused on developing our R&D assets and establishing partnerships to leverage the value of our technology to help protect health.
FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated …
The FDA amended the emergency use authorization of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula.
- Some results have been removed